What is Neurontin?

Neurontin (gabapentin) was approved by the Food and Drug Administration (FDA) in 1994 for the control of partial seizures due to epilepsy in adults and children. It is also approved for management of postherpetic neuralgia (PHN) caused by shingles (herpes zoster). Neurontin affects chemical and nerves in the body that are involved in the cause of seizures and some types of pain. The exact way it works is unknown. Neurontin was originally sold by Parke-Davis, a subsidiary of Warner-Lambert, which in turn was acquired by Pfizer, Inc., in 2000. The Neurontin drug is typically prescribed with other medication for controlling partial seizures associated with epilepsy, but used alone for the treatment of PHN. Neurontin comes is 100, 300 and 400 mg capsules, 600 and 800 mg tablets, and is available in an oral solution form.

The information on this page is meant to provide a general overview of the law. The laws in your state and/or city may deviate significantly from those described here. If you have specific questions related to your situation you should speak with a local attorney.

Related Topics In This Section

Additional Neurontin Articles

Search LawInfo's Neurontin Resources